Robert A. Kyle is a professor of medicine, Laboratory Medicine and Pathology at the Mayo Clinic. He specializes in the care of patients with plasma cell dyscrasias. Throughout his career Kyle has published more than 1,850 scientific papers and abstracts on myeloma and other plasma cell disorders...[1] Some of Dr. Kyle's most notable scientific contributions include naming the disorder known as Monoclonal gammopathy of undetermined significance (MGUS) as well as establishing the epidemiology and long-term prognosis of MGUS.[2][3][4]

Education

Personal life

Early life

Kyle grew up on a rural farm in North Dakota during the 1930s and 1940s. During this time he attended a one-room school house from which he graduated in 1944 at the age of 16. Shortly after graduating from high school he was almost drafted to serve in World War II, but shortly after he reported to Fort Snelling the U.S. made an official decision to no longer draft adolescents under the age of 18. Because of this, Robert was then able to return to the North Dakota school of Forestry and complete his AA degree[6]

Philately

Kyle first became interested in stamp collecting (Philately) as a young boy, but it was not until he suffered a dislocated lumbar disc in 1965 that he found time to increase his stamp collecting activity. In the process of pursuing this interest he has received a number of awards including the John Brain Medal, the Myrtle Watt Award, and the award of Distinguished Topical Philatelist.[7]

Notable awards

[8]

References

  1. ↑ "Robert A. Kyle". Hematology.org. Retrieved 19 August 2022.
  2. ↑ Kyle, RA; Therneau, TM; Rajkumar, SV; Larson, DR; Plevak, MF; Offord, JR; Dispenzieri, A; Katzmann, JA; Melton LJ, 3rd (30 March 2006). "Prevalence of monoclonal gammopathy of undetermined significance". The New England Journal of Medicine. 354 (13): 1362–9. doi:10.1056/NEJMoa054494. PMID 16571879.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  3. ↑ Kyle, RA; Remstein, ED; Therneau, TM; Dispenzieri, A; Kurtin, PJ; Hodnefield, JM; Larson, DR; Plevak, MF; Jelinek, DF; Fonseca, R; Melton LJ, 3rd; Rajkumar, SV (21 June 2007). "Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma". The New England Journal of Medicine. 356 (25): 2582–90. doi:10.1056/NEJMoa070389. PMID 17582068.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  4. ↑ Kyle, RA; Gertz, MA; Witzig, TE; Lust, JA; Lacy, MQ; Dispenzieri, A; Fonseca, R; Rajkumar, SV; Offord, JR; Larson, DR; Plevak, ME; Therneau, TM; Greipp, PR (January 2003). "Review of 1027 patients with newly diagnosed multiple myeloma". Mayo Clinic Proceedings. 78 (1): 21–33. doi:10.4065/78.1.21. PMID 12528874.
  5. ↑ "Robert A. Kyle, M.D." mayoclinic.org.
  6. ↑ "Pulling Back the Curtain: Robert A. Kyle, MD". ashpublications.org. Retrieved 20 August 2022.
  7. ↑ "Hemo-philately: Robert A. Kyle, MD". ashpublications.org. Retrieved 20 August 2022.
  8. ↑ "Robert A. Kyle, M.D." mayoclinic.org.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.